The effect of L-dopa on exploratory activity after catecholamine receptors blocking agents.
D000818:Animals; D001545:Benserazide / Q000494:pharmacology; D002746:Chlorpromazine / Q000008:administration & dosage / Q000494:pharmacology; D003984:Dibenzazepines / Q000494:pharmacology; D004347:Drug Interactions; D005106:Exploratory Behavior / Q000187:drug effects*; D006220:Haloperidol / Q000008:administration & dosage / Q000494:pharmacology; D007980:Levodopa / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D051379:Mice; D010643:Phenoxybenzamine / Q000008:administration & dosage / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D013881:Thioridazine / Q000008:administration & dosage / Q000494:pharmacology; D013997:Time Factors
D003984:Dibenzazepines; D010879:Piperazines; D010643:Phenoxybenzamine; D007980:Levodopa; D001545:Benserazide; D006220:Haloperidol; D013881:Thioridazine; D002746:Chlorpromazine